ASX:AR3 Australian Rare Earths (AR3) Stock Price, News & Analysis → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free AR3 Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Australian Rare Earths alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Australian Rare Earths Stock (ASX:AR3)Australian Rare Earths Limited engages in the exploration and development of rare earths mineral resource opportunities in Australia. Its flagship project is the Koppamurra project located in South Australia and Victoria. The company was formerly known as Tawel Exploration Pty Ltd and changed its name to Australian Rare Earths Limited in March 2021. Australian Rare Earths Limited was incorporated in 2019 and is headquartered in Adelaide, Australia.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> AR3 Stock News HeadlinesJune 18, 2023 | reuters.comLynas Rare Earths' Kalgoorlie facility faces labour shortagesSeptember 21, 2022 | msn.comRare Diamonds That Fell to Earth Came From Dwarf Planet, Scientists SayApril 19, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.September 8, 2022 | nz.finance.yahoo.comWe're Not Very Worried About Australian Rare Earths' (ASX:AR3) Cash Burn RateAugust 29, 2022 | au.finance.yahoo.comAustralian Rare Earths Limited (AR3.AX)August 13, 2022 | investing.comAustralian Rare Earths Ltd (AR3)August 1, 2022 | yahoo.comEnormous debris from SpaceX craft crashes in AustraliaSee More Headlines Receive AR3 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Rare Earths and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Other Industrial Metals & Mining Sub-IndustryN/A Current SymbolASX:AR3 CUSIPN/A CIKN/A Webwww.ar3.com.au Phone1300 646 100FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,380,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-17.09% Return on Assets-11.32% Debt Debt-to-Equity Ratio1.79 Current Ratio13.25 Quick Ratio10.39 Sales & Book Value Annual Sales$71,342.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.15 per share Price / BookN/AMiscellaneous Outstanding Shares155,920,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.39 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Travis BeinkeChief Executive OfficerMr. Noel WhitcherCFO & Joint Company SecretaryMr. Rickie James Pobjoy B.Sc.Technical Director & Executive DirectorKey CompetitorsA-Cap EnergyASX:ACBAccelerate ResourcesASX:AX8Accent ResourcesASX:ACSACDC MetalsASX:ADCAclara ResourcesTSE:ARA.TOView All CompetitorsInsidersAngus BarkerBought 10,000 shares on 11/28/2023Total: $1,600.00 ($0.16/share)Rickie PobjoySold 16,667 sharesTotal: $4,583.43 ($0.28/share)Angus BarkerBought 25,000 shares on 5/5/2023Total: $10,025.00 ($0.40/share)Angus BarkerBought 25,000 shares on 5/3/2023Total: $8,900.00 ($0.36/share)Angus BarkerBought 25,000 shares on 5/1/2023Total: $9,400.00 ($0.38/share) This page (ASX:AR3) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Rare Earths Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.